Weekly Signals Desk | Five Notable Valuation Disconnects from the FMP API (Aug 17-21)

Four of this week's five widest modeled gaps belong to companies that were repriced by an event. Charter closed a transformational merger, Fiserv replaced its chief executive and cut guidance, Olin lost capacity to an equipment failure, and Maximus had a performance-incentive mechanism suspended by its largest customer. CVS is the outlier: it raised guidance and fell anyway. Read across the five, the screen is not describing a sector or a style, it is describing five separate arguments about how much of a disrupted year should be treated as the new base.

In this edition of the Weekly Signals Desk, we run the FMP DCF Valuation API across those five names, compute the implied gap against the live quote so the two printed figures reconcile, and set out what each gap depends on. A large modelled spread reflects the assumptions inside the model rather than a prediction about the share price, and in at least two of these cases the assumptions are doing most of the work.

Key Takeaways

• Implied gaps run from 208.6% to 607.3%, but the width of a gap says almost nothing about its reliability: the two widest here rest on the least stable free cash flow bases.
• Charter and Olin both carry leverage and pending or just-completed structural change, so an equity DCF overstates the per-share result until the new capital structure is reflected.
• Fiserv and Maximus show the same mechanic from opposite ends: reported earnings compressed by transformation and working-capital effects while cash conversion held, which widens a modeled gap without changing the business.
• CVS is the only name where the gap coexists with raised guidance, which shifts the question from earnings quality to how much of a disclosed 2027 headwind the model has absorbed.

The Five Widest Gaps on This Week's Screen

Charter Communications, Inc. (CHTR)

DCF Value: $1,062.18 — Market Price: $150.17 → Upside Potential: 607.3%

Charter carries the widest modeled gap on this week's screen, with intrinsic value placed at $1,062.18 per share against a market price of $150.17. A spread of that magnitude is a statement about the model as much as about the equity. Cable generates large, predictable operating cash flow, and a standard discounted cash flow run on the equity treats that stream as if the capital structure sitting in front of it were incidental. It is not. Total debt stood at $93.8 billion at the end of June against net leverage of 4.18x, so the cash flows the model is discounting are substantially pre-committed.

The operating picture behind the number is also in transition rather than in decline. Second-quarter revenue slipped 1.7% and adjusted EBITDA fell 4.3%, with broadband relationships down 172,000 in the quarter against 80,000 a year earlier, while mobile lines added 406,000. Management characterised its retention and pricing approach as too aggressive and moved the full-year EBITDA outlook to a modest decline from flat. Capital intensity is the other moving part: roughly $11.4 billion of capital expenditure this year against a stated path below $8 billion by 2028, which means any single-year free cash flow figure understates the normalised level by a wide margin, and a model anchored on 2026 will read very differently from one anchored on 2029.

The timing here is unusually awkward for a valuation screen. The Cox transaction closed on 20 August, inside the week this screen covers, bringing roughly $12 billion of assumed debt and finance leases, convertible preferred units, and a share count that leaves the counterparty with about a quarter of the fully diluted equity. The modeled value predates that structure entirely. FMP's Balance Sheet Statement API is the necessary companion here rather than an optional one, because until the post-close debt, preferred obligations and share count are reflected, the per-share output is being computed against a company that no longer exists in that form. The variables worth following are broadband trend, the capital expenditure glide path, and whether the stated 3.5x leverage target and the $800 million synergy figure begin appearing in reported numbers.

Fiserv, Inc. (FISV)

DCF Value: $318.79 — Market Price: $52.58 → Upside Potential: 506.3%

Fiserv shows a modeled value of $318.79 against a market price of $52.58. What distinguishes this entry from the rest of the screen is that the price collapse is recent and documented rather than gradual: the shares have fallen roughly 78% from a 52-week high of $238.59, with the single worst session on record in late October 2025 removing about $30 billion of market value in a day. A model built on the multi-year cash flow record will therefore anchor on a company that no longer resembles the one currently reporting.

The second quarter reported on 6 August is the crux of the disagreement. Organic revenue declined 5% and adjusted operating margin fell to 31.8% from 39.6%, with full-year organic growth guidance cut to a range straddling zero and adjusted EPS guidance reduced to $7.20 to $7.40. Management attributed the reset to timing rather than structure, itemising delayed contracted revenue, hardware, Argentina and divestitures. Yet free cash flow conversion ran above 100% in the quarter while transformation expenses and severance suppressed reported earnings. That combination, weak accounting profit alongside intact cash generation, is precisely the shape that widens a DCF gap without the underlying cash economics having moved much at all.

The governance overlay matters to how the gap should be read. A chief executive appointed in May 2025 left in June 2026, an activist letter in late July pressed for a full portfolio review rather than piecemeal disposals, and a securities class action covering a 2024 to 2025 class period alleges that merchant migration temporarily flattered Clover growth metrics. Divestitures are actively shrinking the revenue base. FMP's Cash Flow Statement API is the dataset that separates the strands, because the question is not whether earnings fell but whether operating cash flow and capital expenditure have moved in the same direction, and whether conversion above 100% reflects durable collection or a working-capital timing benefit. Clover gross payment volume growth and margin trajectory are the two series to follow.

Olin Corporation (OLN)

DCF Value: $75.04 — Market Price: $18.40 → Upside Potential: 307.8%

Olin's modeled value of $75.04 sits against a market price of $18.40. This is the clearest cyclical case on the screen and the one where base-year selection dominates the output. Chlor-alkali and epoxy are sitting near trough conditions, and the model is being fed a year that includes a Freeport vinyl chloride monomer outage that removed roughly $40 million from second-quarter adjusted EBITDA with a further $20 million expected in the third, and full capacity not anticipated until the fourth. A discounted cash flow that normalises off a year containing a discrete equipment failure will produce a large gap almost mechanically.

The segment detail is more encouraging than the headline. Epoxy earned $16.0 million against a loss of $23.7 million a year earlier, its strongest result in more than three years, and Winchester contributed $28.1 million on improving commercial ammunition demand helped by import tariffs, partly offset by copper and brass tariff costs. Chlor-alkali earnings fell, with second-quarter caustic and EDC pricing flattered by conflict-related supply disruption that management expected to unwind. The structural cost programme targets $250 million of savings by 2028 with more than $100 million incremental this year. Against that, first-half free cash flow was negative $113.4 million and net leverage stood at 5.0x on a roughly $2.1 billion equity market capitalisation, which is the reason the equity is priced where it is.

There is also a corporate-form problem the model cannot see. The all-stock merger of equals with Huntsman announced in June, forming a combined group with roughly $12.5 billion of revenue and a $400 million synergy target, is expected to close in the first half of 2027, which changes the share count and the asset base before most of the modeled cash flows arrive. FMP's Revenue Product Segmentation API is the useful instrument for this name, because the interpretation depends entirely on which of the three businesses is being credited with the recovery. The data suggests this is an area to monitor through segment earnings and the leverage path rather than through the headline spread.

CVS Health Corporation (CVS)

DCF Value: $364.37 — Market Price: $93.02 → Upside Potential: 291.7%

CVS presents a modeled value of $364.37 against $93.02, and it is the only name on this screen where the gap sits alongside improving disclosed results. Second-quarter revenue of $106.1 billion grew 7.3%, adjusted operating income rose about 35%, and the company raised full-year adjusted EPS guidance to $7.90 to $8.10 from $7.30 to $7.50 while lifting its operating cash flow floor by roughly $2 billion. The benefits segment did most of the work, with medical benefit ratio improvement of around 250 basis points, though a portion of the prior-year comparison contained favourable development.

The shares fell sharply on the print regardless, which is the interesting part. What the market reacted to was not the quarter but the forward commentary: continued 340B pressure in health services and expected membership attrition at Caremark as it transitions toward net-cost pricing. Management set a 2027 adjusted EPS floor of at least $8.44 and reiterated a mid-teens growth path through 2028 while keeping a cautious view on cost trend. So the disagreement is quite precisely located: the model is discounting a cash flow base that management has just raised, while the market is pricing a disclosed step-down in the composition of that cash flow.

Two regulatory items belong in the frame. A July settlement resolved the insulin rebate antitrust matter involving Caremark with a large multi-year consumer savings commitment plus structural provisions on fee delinking and rebate pass-through, and a state attorney general inquiry into pharmacy steering remains open. Star ratings for plan-year 2026 placed just over 81% of Medicare Advantage members in four-star-or-better plans, down from 88% a year earlier, which feeds directly into future revenue per member. FMP's Financial Estimates API is the right cross-check here, since the question is whether consensus forward EPS has actually absorbed the 2027 Caremark and 340B commentary or is still tracking the raised 2026 figure.

Maximus, Inc. (MMS)

DCF Value: $179.65 — Market Price: $58.22 → Upside Potential: 208.6%

Maximus carries the narrowest gap in the group, with a modeled value of $179.65 against $58.22, and the cleanest single explanation for it. Fiscal third-quarter revenue fell 5.2% to $1.28 billion against a prior-year period that contained elevated natural-disaster support and temporary clinical volumes, yet operating margin still improved 30 basis points and adjusted EPS rose. The share price fell nearly 10% on the report anyway, because guidance came down.

What brought it down was narrow and dated. A modification to the Veterans Affairs medical disability examinations programme paused performance incentives and disincentives from 1 July through 31 December 2026, worth roughly $0.35 per share, and management reduced adjusted EPS guidance to $7.90 to $8.20 and the margin outlook to about 13.7%. Separately, quarterly free cash flow was negative $137 million on days sales outstanding of 98, with $245 million collected in the weeks immediately after quarter end and DSO guided below 70 by year end. A discounted cash flow that takes the most recent period as its base is therefore reading a collections timing effect as a cash flow deterioration, which is a large part of why the gap looks as wide as it does.

The forward picture is genuinely mixed rather than uniformly weak, which is what makes this one worth the work. Total pipeline stands at $50.4 billion with 57% new work, but trailing twelve-month book-to-bill is around 0.5x against declining revenue, and management described procurement delays and scope revisions across the federal civilian market. Offsetting that, a court declined to enjoin Medicaid work requirements in late July, leaving a 1 January 2027 implementation date and roughly 21 million expansion beneficiaries facing semiannual redeterminations, which is directly addressable volume. FMP's Key Metrics TTM API is the practical tool here, because days sales outstanding and free cash flow conversion are the two series that determine whether the negative quarter was timing or trend.

One Signal, Five Different Sources of Doubt

Reading the five together, the striking thing is that the ranking by implied upside is close to an inverse ranking by reliability. Charter and Olin sit at the top and both carry the structural problem that standard equity DCF handles worst: material leverage plus a capital structure that is changing. Fiserv and Maximus sit in the middle and share a subtler distortion, where reported earnings were compressed by transformation charges, severance and working-capital timing while cash conversion held up, which widens the modeled gap without the cash economics having moved. CVS sits at the bottom of the five and is the only one where the model and the market are arguing about the future rather than about how to read the past.

That distinction is worth holding onto because it changes what the screen is for. A large gap is not evidence of mispricing; it is evidence that the model's assumption set and the market's assumption set have separated, and the useful work is identifying which assumption is carrying the weight. For Charter it is the discount rate and the treatment of debt. For Olin it is the choice of base year. For Fiserv and Maximus it is whether a disrupted period is transitional. For CVS it is how far forward the disclosed 2027 headwind has already been pushed into estimates.

The mechanics of testing that are straightforward once the question is framed properly. Running the same names through FMP's Levered DCF API alongside the standard model isolates how much of each gap is a financing artefact rather than an operating one, which is the single most useful check for Charter and Olin. The Enterprise Values API then shifts the comparison from equity value to enterprise value, where debt and cash are inside the frame rather than outside it, and that is where a leveraged cable operator and an unlevered services business become comparable at all. Within the wider FMP data framework, the Owner Earnings API provides an independent construction of distributable cash that does not inherit the same base-year sensitivity, which is a genuine cross-check rather than a restatement of the same number.

Two further datasets close the loop on the structural risks. The Financial Scores API gives a fast read on balance-sheet resilience, which matters most where the thesis requires the company to hold its position through a trough, as at Olin and Fiserv. And because two of these five have been reshaped by transactions inside the last quarter, the Latest Mergers and Acquisitions API is what keeps the valuation record honest about which corporate entity the cash flows actually belong to. Assembled that way, the screen stops presenting itself as a list of undervalued companies and starts functioning as a properly ordered research queue, which is the only claim the underlying data supports.

Turning DCF Snapshots Into a Live, Repeatable Signal

A single DCF output can highlight a pricing gap, but on its own it's just a snapshot. Market prices update continuously, while model inputs—growth rates, margins, discount assumptions—shift as new data comes in. To make the signal usable, the focus needs to move from one-off checks to consistent data capture. That means running the same extraction on a schedule, storing each pull, and observing how valuation spreads change over time rather than treating them as isolated readings.

Before starting the workflow, confirm that your API key is properly configured and accessible in your environment.

Step 1. Query the DCF Valuation API

The workflow starts with the DCF Valuation API, which serves as the foundation for the entire process. This endpoint returns both the modeled intrinsic value and the current market price in one response, removing the need to reconcile multiple data sources before analysis begins. Having valuation and price captured together ensures consistency and reduces the risk of timing mismatches that can distort comparisons.

Sample response

[ { "symbol": "AAPL", "date": "2025-02-04", "dcf": 147.27, "Stock Price": 231.80 } ]

Step 2. Compute the Upside

With both fields in hand, the next step is to normalize the gap. Converting the difference between DCF and market price into a percentage allows the results to be compared across names with very different share prices:

Upside % = (DCF - Stock Price) / Stock Price × 100

In the example above, the calculation produces roughly -36%, indicating the stock is trading above the modeled intrinsic value. Positive figures flag the opposite condition—where price sits below DCF—which is the core signal this screen is designed to capture.

Step 3. Scale It into a Screening Loop

The workflow becomes materially more useful once this logic is applied at scale. Running the DCF endpoint across a defined universe, calculating the percentage spread for each symbol, storing the results, and ranking them by upside converts a static check into a living screen. When automated on a recurring cadence, the process continuously surfaces where price and intrinsic value are drifting further apart or beginning to converge, making it easier to monitor valuation pressure as market conditions shift.

Stabilizing the Workflow Before Scaling It

Before expanding a valuation screen across hundreds or thousands of symbols, the more important question is whether the process behaves consistently under repeat conditions. Early-stage testing is less about market coverage and more about validation: confirming that DCF outputs reconcile properly, percentage spreads calculate cleanly, and rankings update logically as new data enters the system. For that stage, the FMP Basic plan is generally enough to establish whether the workflow itself is dependable.

Once the mechanics are stable, scaling becomes an infrastructure decision rather than a methodological one. The same extraction logic, normalization process, and ranking framework can simply be applied across a broader universe using the FMP Starter plan, which adds wider market coverage and deeper historical access. The signal itself does not change — only the breadth of the environment it runs against. That consistency matters because it keeps comparisons aligned as the dataset expands.

For workflows operating on tighter refresh cycles or across international markets, throughput starts to matter more than screen construction. The FMP Premium plan supports that transition with higher request capacity and broader exchange access, making it easier to run the process continuously around earnings releases, estimate revisions, or macro-driven volatility windows. At that stage, the screen stops functioning like a periodic valuation check and starts behaving more like part of the ongoing research infrastructure.

When a Valuation Framework Evolves into Research Infrastructure

Signals that consistently hold up under market pressure rarely remain confined to a single analyst workflow. Once a valuation framework starts influencing sector reviews, allocation discussions, or risk meetings, the limitations of fragmented implementations become more visible. Teams may be using the same conceptual model, but differences in ticker universes, update frequency, normalization logic, or historical storage quickly create inconsistencies that undermine comparability across desks.

In practice, the analysts closest to the workflow often become the internal drivers of standardization. After refining the screen through repeated market cycles, the priority shifts away from experimentation and toward consistency: locking calculation logic, aligning data inputs, and ensuring that everyone evaluating the signal is working from the same underlying assumptions. That transition matters because valuation frameworks become materially more useful once they can be referenced across teams without requiring reconciliation between separate spreadsheets or independently maintained scripts.

As adoption expands across research groups, portfolio teams, or regional desks, the infrastructure surrounding the workflow becomes as important as the screen itself. Shared dashboards reduce duplication, centralized storage preserves historical outputs for auditability, and permission controls help prevent silent methodology drift over time. The objective is not simply operational efficiency — it is analytical coherence. When multiple teams are discussing valuation dispersion, factor exposure, or earnings sensitivity, confidence in the conversation depends on confidence in the underlying data framework being synchronized across the organization.

That is typically the point where desk-level tooling evolves into institutional research infrastructure. Frameworks that began as analyst-built screens often migrate toward more formal environments designed for controlled access, consistent delivery, and governance across broader user groups. An institutional setup such as the FMP Enterprise Plan becomes relevant less as a scaling upgrade and more as a way to preserve methodological integrity as usage broadens across teams, strategies, and regions.

Tracking These Gaps Beyond a Single Reading

Five names, five different assumptions doing the heavy lifting, and one shared conclusion: the width of a modeled gap is a measure of disagreement, not of opportunity. Re-running the FMP DCF Valuation API against the same names as capital structures settle and base years roll forward is what turns a weekly snapshot into a record of whether the disagreement is resolving through price or through fundamentals.

Expand your watchlist with our previous deep dive: Signals Desk Weekly Take via FMP API | Five Biggest Stock Movers (Aug 10-14)

Disclosure: Signals Desk content is provided for informational and analytical purposes only and does not constitute investment advice or trade recommendations. The analysis reflects interpretation of market data and publicly disclosed or third-party information, including data accessed via Financial Modeling Prep APIs, at the time of publication. Signals discussed are probabilistic, can be wrong, and may change as market conditions and consensus data evolve. This content should be considered alongside broader research, individual objectives, and risk assessment.